ARDELYX, INC. — Director's Dealing 2014

Jun 19, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2014-06-18

Reporting Person: Rosenbaum David P. (VP, Drug Development)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25880	Direct
Common Stock	77592	Indirect
Common Stock	2777	Indirect
Common Stock	2777	Indirect
Common Stock	2777	Indirect

Footnotes

F1: Reflects a one-for-nine reverse split of the Issuer's stock effected immediately prior to the consummation of the Issuer's initial public offering.

F2: The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.

F3: The shares are directly held by the reporting person's son.

F4: The shares are directly held by the reporting person's daughter.